Which gut health tests are worth it? Microbiome, stool and SIBO breath tests compared

I have no commercial interest in any of these tests or their providers. See how I work and how treatment is structured.

Dr Shehan Wijesingha

Dr Shehan Wijesingha MD, M.TCM, BMedSci, DipAP, CPT

Reviewed 12 October 2026 Reading time ~ 24 minutes

A patient of mine went through a very stressful period in his life, and his gut has never been the same. He went to conventional doctors and functional medicine doctors and did everything from endoscopies to stool tests to breath tests. He took the antibiotics. He took the proton pump inhibitors. Yet his gut only continued to get worse.

Another patient came to see me with long-standing headaches and bloating. She’s very smart, yet it still took her years to see that her symptoms got worse after taking repeated ibuprofen for those headaches.

These two patients have something in common with a number of patients I see. And they are often some of the most difficult to treat: doctors doing the right thing from their perspective and following the guidelines, yet the treatment became part of the disease.

For issues like long-standing pain, fatigue, trauma, anxiety and nervous system dysregulation, I usually see real change quickly. But these gut cases, especially when worsened by strong medication, resisted. Ancient medicine never had to deal with a gut made worse by strong medication. This is a new problem, and it may need a new way of thinking. The truth is, I don’t like failing, so I went back to study. I researched as much as I could on nutrition, herbs, supplements, protocols and testing, from books to scientific papers, across conventional medicine, functional medicine, Ayurveda and Chinese medicine. There had to be something I was missing.

This article is a small part of that research: which tests can help patients who have suffered for years with problems in their gut?

Summary

  • Gut microbiome imbalance has been linked to obesity, diabetes, mental health conditions, inflammatory bowel disease, colorectal cancer and more.
  • The tests your doctor can order, and why: faecal calprotectin, FIT, faecal elastase, H. pylori, coeliac and stool tests.
  • How commercial gut microbiome tests work: 16S, shotgun metagenomics, PCR, PCR plus culture, metatranscriptomics and metabolomics. If you’re going to spend money on one, know what it measures.
  • Stool tests may not reflect your whole intestine. Results aren’t standardised, reference ranges could be biased towards profit, and marketing can target vulnerable patients.
  • PCR is more sensitive for organisms such as parasites, and may help show which antibiotics will work for H. pylori.
  • SIBO is quite a trendy diagnosis, often tested with a breath test and treated with antibiotics. If you wouldn’t want the treatment, think about what the test is for.
  • Gut health tests can provide value, but I believe the future will combine modern scientific rigour with ancient healing systems such as Ayurveda and Chinese medicine.

What is the gut microbiome, and what does it do?

Your gut microbiome includes 30 to 40 trillion bacteria living in your intestine. This is slightly more than the number of cells you have in your entire human body.1 This microbiome is shaped by food you eat, the medication you take, where you live, your age, stress levels, smoking and alcohol and how long it takes food to move through your bowels.2, 3 And two people who feel completely healthy can have very different microbiomes.4 Furthermore, over recent generations, our gut microbiome has had a significant reduction in its diversity, linked to a food supply that’s less diverse and more processed, industrialisation, advances in medical practice and sanitisation.5–7 All of this complicates how to define what a healthy microbiome is.8

And whilst a lot of people associate your gut microbiome with bacteria, it also includes viruses, fungi, protozoa and archaea.9 And this association has crept into the definition of dysbiosis, where the population of “bacteria” gets out of balance.10 But balance is what is key here. Even a healthy gut contains bacteria some may label as bad. E. coli, for example, is the classic “bad bacteria”, but some strains produce vitamin K.11, 12 This is why I think labelling bacteria as “good” and “bad” is too simplistic, and the same may be true of some parasites.13, 14 Nevertheless, a gut microbiome that is out of balance has been associated with a number of problems:

Obesity: In obese mice, and possibly individuals, there may be more bacteria that are more efficient at breaking down carbohydrates and releasing more energy to be stored as fat, which may worsen insulin resistance, making it harder to regulate blood sugar.15, 16

Diabetes: Your gut bacteria’s enzymes and metabolic pathways can influence how effectively you can handle the carbohydrates you eat.17 Their by-products can help your gut release GLP-1, the hormone that Ozempic and other GLP-1 medications mimic to signal to your pancreas to release insulin.18 And a deficiency of butyrate producers is linked to diabetes.19–21

Mental health: Around 90% of your body’s serotonin is made in your gut, and it circulates through the whole body, though it does not enter the brain.22 Some gut bacteria can produce GABA, the calming neurotransmitter,23 and in animal studies both signal to the brain via the vagus nerve.24, 25 And an imbalanced population may contribute to a heightened cortisol response.26, 27 This constant communication between the gut and the brain is what we call the gut-brain axis.27 Your gut bacteria can also produce and stimulate hormones like dopamine, which may impact your mood, your stress levels and your quality of sleep.28, 29

Systemic inflammation: Your gut bacteria help control your immune system and inflammation, at a local and a systemic level, and help you obtain energy and vitamins from food.30, 31 Short-chain fatty acids made by your gut bacteria, like butyrate, acetate and propionate, reduce inflammation and maintain the integrity of the gut barrier.32 It makes sense that research keeps linking the gut microbiome to a number of additional medical conditions such as inflammatory bowel disease, metabolic disease, cardiovascular disease, colorectal cancer, ADHD and eczema.33–38

As the public becomes more aware of information such as this and seeks answers to their health issues, there will be more demand for ways to test this, resulting in more research being pushed in this area which companies can monetise. The main question therefore has to be: how useful are these tests?

Conventional stool tests

If you went down the conventional pathway, certain symptoms such as anaemia, loss of weight, loss of appetite, recent or worsening symptoms, black stools or vomiting blood, difficulty swallowing, bleeding from the back passage, waking at night with diarrhoea, a family history of bowel cancer or IBD, or new symptoms over 50 would typically be investigated by the relevant pathways promptly.39 And say you mentioned to a gastroenterologist that you have issues related to your gut, such as bloating, constipation, stomach pain and so on. Some of the specific tests they may order to help determine the next stage of treatment would be:

  • Faecal calprotectin: to differentiate between inflammation in your gut, indicative of something like inflammatory bowel disease, or IBS.40

  • Faecal immunochemical test (FIT): to check if there’s blood in your stools, and assess your risk for colon cancer to decide whether you need a colonoscopy.41

  • Faecal elastase: to see if your pancreas is releasing enough enzymes to help digest fats and protein.42

  • H. pylori testing: if upper gut pain or burning to decide whether you need antibiotics and proton pump inhibitors to eradicate this bacterium.43, 44

  • Stool microscopy and culture: culture to look for bacteria, and microscopy for parasites, to see which treatment can target it.45

  • A breath test: to assess for the likelihood of excessive bacterial growth in your small intestine, to see which antibiotics may most likely help.46, 47

  • Anti-tTG antibodies and total IgA: if a doctor suspects coeliac disease.48, 49

Commercial testing, however, now claims to take this testing significantly further. But are these tests worth it?

How do gut microbiome tests work?

Commercial microbiome tests typically claim to map the organisms living in your gut, assess the balance between them, measure markers of digestion, immune activity and inflammation at the gut level, and then provide a personalised plan to optimise all of it.

With all of these companies, you order a kit, collect a stool sample at home, and post it to a lab. And you will then often receive a score, an assessment of your gut diversity, and suggested ways of improving it with diet or probiotic recommendations, usually using population-level data and AI algorithms.50

The key to whether this could be of use is to first understand these methods. There are six main ways these tests work, and each tells you something different:

16S rRNA sequencing: reads a single gene shared by all bacteria to identify them, but mostly only down to the genus level. It’s like reading only surnames. You learn which families of bacteria live in your gut, usually without their first names (the exact species), and it misses fungi, viruses and parasites. Companies such as Biomesight in the UK use this method to give you a broad bacterial profile of your gut.51

Shotgun metagenomics: reads a sample of all the DNA of all the bacteria, fungi, viruses and parasites in the sample and pieces them back together. It identifies most microbes down to species and sometimes strain level, and reveals what the microbes are capable of doing. It’s like reading the full census: first names and surnames, plus every resident’s CV, meaning what they’re capable of doing. Zoe in the UK uses this method to identify your “good” and “bad” bacteria and get a broad species-level bacterial map.52

PCR: searches for, detects and amplifies the DNA of a fixed list of named specific, pre-selected organisms and measures how much of each one’s DNA is there. It’s like checking a guest list. So it’s highly sensitive for those targets but blind to everything else in the sample. Tests such as the GI-MAP use PCR to detect microbial DNA, and they claim greater sensitivity in doing so.45

PCR plus culture: adds the older method of growing bacteria from the sample in a lab dish. Culture shows which bacteria are alive and lets the lab test which agents kill them. Tests such as Doctor’s Data GI360 and Genova GI Effects combine the benefits of PCR with culture.

Metatranscriptomics and metabolomics: Metatranscriptomics measures the microbes’ RNA (instead of the DNA), which is the short-lived message a microbe makes when it switches a gene on, showing which microbial genes are actively switched on and working in your gut at that moment. Metabolomics measures the chemicals in your stool, many made by microbes, such as short-chain fatty acids or vitamins. It’s like listening in on the town’s phone calls: it shows which jobs are under way today and also checking what the town has produced by the end of the day respectively. Companies such as Viome use metatranscriptomics to measure what your microbes are actively doing.53, 54

In addition to the organisms themselves, some of these panels may also measure additional markers, such as zonulin, secretory IgA, beta-glucuronidase and blood metabolites to provide claimed markers for intestinal permeability, immune activity, hormone and toxin recycling and nutrient conversion respectively.55–58

The case against most gut microbiome tests

Stool only shows what leaves your gut

I’ll start with the most obvious concern I have with gut microbiome tests: they measure the microorganisms through the stool, which leaves your large intestine. What about the microorganisms further up, in your small intestine, for example? How is this an accurate measure of that, and therefore how can it be an accurate measure of the cause of problems in your gut, which includes your full intestine, not just what leaves at the end of it?59, 60

Same sample, different answers

Even if this were resolved, when standardised human stool material was sent to seven consumer microbiome tests, different providers gave different answers on the same sample.61 So the validity of the results of these tests comes into question.62

Who sets the reference ranges?

Let’s say a stool sample was able to give a good understanding of what’s happening in your entire digestive system, and the results were standardised. Then who creates the reference ranges?63, 64 If you are a company, you could set cut-offs that favour the products you sell, because we don’t even know with confidence, from the most current scientific literature, what is normal in the microbiome.8, 50, 65 So how do these companies know? And are they transparent about how they create the reference ranges? Companies do seem to be starting to describe how they determine good and bad bacteria, how they define good and not optimal scores, and how they develop their ranges, which is a step in the positive direction.66–68

Studies funded by competitors

Between companies, what obscures things even further is that they can fund studies to compete with each other. One example: a study funded by Doctor’s Data, a GI-MAP competitor, whose employee co-wrote it, reported a high number of false positives, with 4 of 7 clean control samples coming back reporting a pathogen at high levels, although disputed.69, 70

Selling the solution

Unfortunately, when patients are vulnerable, they want a solution. With gut health being high on the wellness agenda, and with many patients trying almost anything, companies can use strong marketing tactics to avoid many of these arguments and sell them the solution.62 That can lead to unnecessary restrictive diets, antibiotics, long courses of antifungals or supplements, and anxiety from scores.50

Why the big trials may never happen

However, there’s a caveat I’d add to all of this. To satisfy the scientists’ criteria for the gut microbiome, you’d have to spend millions on randomised controlled trials. These would have to prove, by keeping most measures the same, that certain medications or supplements, used in a personalised way, can improve patient outcomes. Some personalised trials have been done,71, 72 but they are small next to the multi-phase trials needed to change clinical guidelines. The honest truth is, this is hard to do at the scale needed, especially when companies keep their algorithms and data private.50, 62 And this method of investigation is very unlikely to work well to account for the personalisation required for individuals, and this is actually one of the problems with our current scientific method.

It’s why, no matter how much gut microbiome research we do, it’s going to be hard to definitively prove what matters in the end: whether patients get better with certain protocols, proven well enough that no specialist can argue with it.

That’s the hardest thing.

The case for gut microbiome tests

Even so, there are some good reasons to consider these tests.

PCR finds what culture misses

Firstly, validated PCR panels are more sensitive than culture for named pathogens and are recognised in hospital laboratories worldwide to guide diagnostics.45, 73 And whilst metabolomics and metatranscriptomics may be the frontier, there’s simply not enough good-quality data to base treatment on this. One problem with culture-based testing is that it favours oxygen-loving bacteria, because these grow in a lab dish more easily. In some cases, the bacteria that grow without oxygen are not just more abundant but may be more important clinically to explain the symptoms going on. DNA methods can pick that up.74

Choosing antibiotics for H. pylori

Secondly, Helicobacter pylori is often treated with two or more antibiotics and a proton pump inhibitor.43, 44 However, stool PCR tests claim to check which antibiotics will work for bacteria such as Helicobacter pylori. If they are as reliable as they claim to be, that could provide real value from a conventional perspective: to rid the body of a bacterium that can contribute to significant long-term health conditions.43, 75

Parasites and fungi

Thirdly, the gut microbiome extends far beyond bacteria, it includes parasites and fungi. Whilst we can check for parasites in the stool through clinical testing, a lot of patients do come back negative with the current methods.73, 76 Therefore, if a test such as PCR, which is more sensitive for parasites and fungi, exists, it could fill a real gap in conventional medicine, where a positive result reflects disease and not harmless carriage.77, 78 And if this testing became more established, I do believe it could change a lot of current clinical guidelines, especially if what becomes apparent is that more gastrointestinal issues have been contributed by fungi and parasites than we have acknowledged.

This is especially important when you consider that, when infection or overgrowth is suspected, the conventional treatment tends to be antibiotics, which target bacteria. If fungi or parasites are contributing more to a person’s current issues, the remaining question is: could we be making patients worse, encouraging, for example, fungi-associated disease to flourish in such a gut environment?79, 80

Faecal transplants

And finally, even though microbiome sequencing research is roughly 20 years old, in one of the most severe bacterial infections, recurrent C. difficile infection, an endorsed treatment is to replace the intestinal microbiome by transplanting faecal microbiota, first described in China around 1,700 years ago.81–84 There does seem to be potential growing value in understanding the microbiome.85 And the consensus recommendation is that a doctor or clinician should order and interpret any test, and that evidence of clinical value is still scarce.50

How is SIBO tested, and how accurate are breath tests?

The biggest problem with stool tests is that they’re measuring the stool that comes out of your large intestine. What about people who have issues with their small intestine? This is where the breath test potentially has some value to add to the diagnosis of SIBO: small intestinal bacterial overgrowth, though breath testing in IBS is contested by specialists.86, 87

How a breath test works

You drink a solution containing either glucose or lactulose, and over the next 2 to 3 hours, you breathe into a bag every 15 to 20 minutes.47 The rationale is that if bacteria have overgrown in your small intestine, they will ferment the carbohydrate early and produce hydrogen, whereas archaea would produce methane. The gas travels in your bloodstream, and you breathe it out through your lungs. An early rise in hydrogen, within 90 minutes, is considered a positive glucose or lactulose breath test for SIBO. This has the potential to differentiate between an overgrowth of archaea, something called IMO (intestinal methanogen overgrowth), and small intestinal bacterial overgrowth, which can determine the antibiotic regimen you can be prescribed.46, 88

The only other way is to put an endoscope through your mouth, which already creates a risk of contamination from the bacteria in your mouth, go directly into your small intestine, aspirate the fluid there, culture it, and measure what’s growing. Obviously, because it’s invasive and costly, this is rarely done, which is why the breath test is far more accessible and available.46, 88

False positives and false negatives

The big problem is how long it takes for the glucose or lactulose to go from your mouth to your colon. If it goes very fast, fermentation could be happening in your colon and not your small intestine, which could give you a diagnosis of small intestinal bacterial overgrowth when the fermentation is actually happening further down. A false positive.89, 90

And the opposite: what happens if the glucose or lactulose doesn’t reach the small bowel in time, because of delayed emptying or glucose being absorbed before it reaches the bacteria? You could technically have SIBO, get a negative result, and be given false reassurance.47, 88 Nevertheless, taking into account that some people barely produce hydrogen at all, this also provides false reassurance.88 And the same issue applies as mentioned above: what happens if it’s not bacteria or archaea in the small intestine at all, but fungi, for example? This test won’t measure that.91

Do you need the test?

Whilst it’s understandable why a lot of people are referred for and take this test, it really comes down to how you want to be treated in the end. If you get diagnosed with SIBO or IMO, the end solution is typically antibiotics.46, 92 Often, at least for the patients I see, the last thing they want is to be treated with antibiotics due to their effect on the gut microbiome, though rifaximin’s lasting effect appears limited.93 So really think it through: if you wouldn’t take the treatment, what does the diagnosis do for you, unless it prompts a search for a further cause, such as slow movement of the gut, low stomach acid, medication or a narrowing after surgery?46, 88

What I would do if I were in your position.

How I assess gut health

There may be ongoing debate between conventional doctors, functional and integrative medicine doctors, natural healthcare practitioners, and scientists for many years to come regarding the usefulness of these tests. But the only thing that matters in the end is: what is the best long-term solution to improve the health of your gut, ideally with as few side effects as possible?

To come to the solution to all of this, I do believe it would be important for modern science, modern medicine, and functional medicine to look at ancient healing traditions such as Ayurveda and Chinese medicine. Their diagnostic and treatment principles for healing the gut go back thousands of years. And I suspect that if and when there is a genuine merging of modern scientific principles with ancient healing philosophy, medicine will return to what it was always meant to be: a healing profession.

Admitting my own bias, considering the way I practise, I do believe the ancient pulse diagnosis, used for centuries in Ayurveda and for thousands of years in Chinese medicine, should be explored in more depth. Having studied and trained in both, I’ve seen how two independent systems, when understood, seem to point to similar ways of understanding what is happening in the entire body through the pulse.94–97 The same can be said of the tongue. These are typically done as standard during consultations in Ayurveda and Chinese medicine. With both Ayurvedic and Chinese medicine practitioners, the more experienced they are, the more accurate I think they can be. I’d advise anyone with an open mind and curiosity to look more into this.

Furthermore, to resolve gut issues, the philosophy of treatment in the modern West will have to shift to how we’ve been doing it for thousands of years. Why? Because I believe it’s a genuine solution.

Germ theory and the terrain

The best example I can give is a frog that develops gut symptoms whilst it is in dirty water. The current Western testing methodology could be viewed as: let's test the frog's stool. Let's test the frog's breath. Let's test the frog's blood. Let's figure out what bad bacteria, fungi or other microorganisms are causing these gut symptoms. Once we find them, let's kill those bacteria, fungi or parasites.

As you can see, a lot of this article has been based on this modern way of thinking so far, which comes from germ theory.98 Ayurveda and Chinese medicine tend to first focus on the terrain: the state of the body the microbes live in.99

But when you look at how we’ve been treating human beings for thousands of years, what we actually do is simply figure out how to take the frog out of the dirty water first. If you don’t take the frog out of the dirty water, the same fungi, bacteria, and parasites will reinfect the frog. And in clean water, the frog’s own body grows stronger and better able to fight them off.100 What I am saying may be controversial now, but I suspect that in the information age, as more and more people become aware, it will be accepted. It’s logical, intuitive, and makes sense.

How I treat gut health

The unfortunate reality is this way of thinking is not as scalable, patentable and profitable as endless testing, medication, supplements and protocols, unlike the simpler solutions ancient healing traditions such as Ayurveda and TCM may provide once the pattern is understood and treated competently.101 You can’t patent ginger, a pulse reading or an acupuncture point. For example:

  • If a person has excess heat, simple ingredients like aloe vera may be used.102
  • If the issue is stemming from the mind, we target the mind, both consciously and subconsciously,103–106 and through the subtle effects of food and herbs.107
  • If the cause is the environment, the first step may be to leave the environment if practical.
  • If there’s a problem with flow in the gut or elsewhere in the body, considering the entire body is interconnected, we can use techniques such as acupuncture, cupping, and massage, which may help release this stagnation.108–111

At the end of the day, what we’re really trying to do is create balance in the mind, body, spirit, and energy.

And at the forefront of microbiome research, the only solutions experts seem to agree on are that you should have a diverse group of microbes and species, supported by eating a diverse range of plants, probiotic and fermented foods, and keeping active.112–114

So my question to you is: what will a gut microbiome test, or any of these tests, do for you, and how can they genuinely help your treatment? Could the personalised solution be to keep up to date with the gut microbiome in the scientific literature as much as possible? Could it be to take an interest in more ancient forms of healing? Could it be to combine all of this?

Regardless of my view or yours, the true solution going forward is for patients to become more empowered, to take charge of their health, and therefore their quality of life. As that happens, maybe medicine can return to a more healing profession, maybe the health of the population can change, maybe the health of our society can take a turn for the better. Who would benefit most from this?

I wish you all the best.

Which gut health tests are worth it?

TestThe question it answersWorth it?
Faecal calprotectinIs there inflammation in your gut, such as inflammatory bowel disease, or is it more likely IBS?Yes, when your doctor suspects it
Faecal immunochemical test (FIT)Is there blood in your stool, and do you need a colonoscopy?Yes, when your doctor suspects it, and in bowel cancer screening
Faecal elastaseIs your pancreas releasing enough enzymes to digest fats and protein?Yes, when your doctor suspects it
H. pylori testingIs H. pylori behind upper gut pain or burning?Yes, if you have those symptoms
Anti-tTG antibodies and total IgADo you have coeliac disease?Yes, if your doctor suspects it
Stool microscopy and cultureIs an infection causing your symptoms?Yes, when infection is suspected
Breath testIs there bacterial or methane-producing overgrowth in your small intestine?Only if you would take the treatment, or if it prompts a search for a further cause
PCR stool panels, such as the GI-MAPAre parasites or other named organisms present that standard tests may miss? Which antibiotics will work for H. pylori?Possibly, when standard tests are negative and symptoms continue, ordered and interpreted by a doctor or clinician
16S sequencing, shotgun metagenomics, metatranscriptomics and metabolomics (such as Biomesight, Zoe and Viome)Which bacteria live in your gut, and what are they doing?Not yet: there isn’t enough good-quality data to base treatment on them
Zonulin, secretory IgA, beta-glucuronidase and other markers in gut microbiome testsIs your gut leaky, how active is its immune system, and how are hormones recycled?Rarely on their own, but they can make sense when the wider picture is taken into context
Pulse and tongue diagnosisWhat pattern sits behind your symptoms?My bias: worth exploring with an experienced Ayurvedic or Chinese medicine practitioner

If you are considering working with me, feel free to

References
  1. Sender R, Fuchs S, Milo R (2016). Revised estimates for the number of human and bacteria cells in the body PLoS Biol 14:e1002533.
  2. Falony G, et al (2016). Population-level analysis of gut microbiome variation Science 352:560-564.
  3. Vujkovic-Cvijin I, et al (2020). Host variables confound gut microbiota studies of human disease Nature 587:448-454.
  4. Human Microbiome Project Consortium (2012). Structure, function and diversity of the healthy human microbiome Nature 486:207-214.
  5. Sonnenburg ED, Sonnenburg JL (2019). The ancestral and industrialized gut microbiota and implications for human health Nat Rev Microbiol 17:383-390.
  6. Vangay P, et al (2018). US immigration westernizes the human gut microbiome Cell 175:962-972.
  7. Maixner F, et al (2021). Hallstatt miners consumed blue cheese and beer during the Iron Age and retained a non-Westernized gut microbiome until the Baroque period Curr Biol 31:5149-5162.
  8. Shanahan F, Ghosh TS, O'Toole PW (2021). The healthy microbiome: what is the definition of a healthy gut microbiome? Gastroenterology 160:483-494.
  9. Rowan-Nash AD, et al (2019). Cross-domain and viral interactions in the microbiome Microbiol Mol Biol Rev 83:e00044-18.
  10. Petersen C, Round JL (2014). Defining dysbiosis and its influence on host immunity and disease Cell Microbiol 16:1024-1033.
  11. Tenaillon O, et al (2010). The population genetics of commensal Escherichia coli Nat Rev Microbiol 8:207-217.
  12. Bentley R, Meganathan R (1982). Biosynthesis of vitamin K (menaquinone) in bacteria Microbiol Rev 46:241-280.
  13. Röser D, et al (2014). Metronidazole therapy for treating dientamoebiasis in children is not associated with better clinical outcomes: a randomized, double-blinded and placebo-controlled clinical trial Clin Infect Dis 58:1692-1699.
  14. Piperni E, et al (2024). Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries Cell 187:4554-4570.
  15. Turnbaugh PJ, et al (2006). An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444:1027-1031.
  16. Corbin KD, et al (2023). Host-diet-gut microbiome interactions influence human energy balance: a randomized clinical trial Nat Commun 14:3161.
  17. Zeevi D, et al (2015). Personalized nutrition by prediction of glycemic responses Cell 163:1079-1094.
  18. Tolhurst G, et al (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2 Diabetes 61:364-371.
  19. Qin J, et al (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes Nature 490:55-60.
  20. Mei Z, et al (2024). Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes Nat Med 30:2265-2276.
  21. Forslund K, et al (2015). Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota Nature 528:262-266.
  22. Gershon MD, Tack J (2007). The serotonin signaling system: from basic understanding to drug development for functional GI disorders Gastroenterology 132:397-414.
  23. Strandwitz P, et al (2019). GABA-modulating bacteria of the human gut microbiota Nat Microbiol 4:396-403.
  24. Bonaz B, Bazin T, Pellissier S (2018). The vagus nerve at the interface of the microbiota-gut-brain axis Front Neurosci 12:49.
  25. Bravo JA, et al (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve Proc Natl Acad Sci USA 108:16050-16055.
  26. Sudo N, et al (2004). Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice J Physiol 558:263-275.
  27. Cryan JF, et al (2019). The microbiota-gut-brain axis Physiol Rev 99:1877-2013.
  28. Valles-Colomer M, et al (2019). The neuroactive potential of the human gut microbiota in quality of life and depression Nat Microbiol 4:623-632.
  29. Olson M, et al (2026). What is the nature of sleep and circadian rhythm health on gastrointestinal microbiota? A systematic review of studies in humans Sleep Med Rev 86:102256.
  30. Belkaid Y, Hand TW (2014). Role of the microbiota in immunity and inflammation Cell 157:121-141.
  31. LeBlanc JG, et al (2013). Bacteria as vitamin suppliers to their host: a gut microbiota perspective Curr Opin Biotechnol 24:160-168.
  32. Koh A, et al (2016). From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites Cell 165:1332-1345.
  33. Schirmer M, et al (2019). Microbial genes and pathways in inflammatory bowel disease Nat Rev Microbiol 17:497-511.
  34. Fan Y, Pedersen O (2021). Gut microbiota in human metabolic health and disease Nat Rev Microbiol 19:55-71.
  35. Tang WHW, et al (2013). Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk N Engl J Med 368:1575-1584.
  36. Wirbel J, et al (2019). Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer Nat Med 25:679-689.
  37. Wang N, et al (2022). Composition of the gut microbiota in attention deficit hyperactivity disorder: a systematic review and meta-analysis Front Endocrinol 13:838941.
  38. Díez-Madueño K, et al (2025). Gut dysbiosis and adult atopic dermatitis: a systematic review J Clin Med 14:19.
  39. NICE . Suspected cancer: recognition and referral (NG12)
  40. NICE . Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (HTG320, formerly DG11)
  41. NICE . Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care (HTG690)
  42. Whitcomb DC, et al (2023). AGA clinical practice update on the epidemiology, evaluation, and management of exocrine pancreatic insufficiency Gastroenterology 165:1292-1301.
  43. Malfertheiner P, et al (2022). Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report Gut 71:1724-1762.
  44. Chey WD, et al (2024). ACG clinical guideline: treatment of Helicobacter pylori infection Am J Gastroenterol 119:1730-1753.
  45. Shane AL, et al (2017). 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea Clin Infect Dis 65:e45-e80.
  46. Pimentel M, et al (2020). ACG clinical guideline: small intestinal bacterial overgrowth Am J Gastroenterol 115:165-178.
  47. Rezaie A, et al (2017). Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus Am J Gastroenterol 112:775-784.
  48. NICE . Coeliac disease: recognition, assessment and management (NG20)
  49. Penny HA, et al (2026). The 2026 British Society of Gastroenterology guidelines on the diagnosis and management of adult coeliac disease Gut. Published online 12 July 2026.
  50. Porcari S, et al (2025). International consensus statement on microbiome testing in clinical practice Lancet Gastroenterol Hepatol 10:154-167.
  51. Johnson JS, et al (2019). Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis Nat Commun 10:5029.
  52. Quince C, et al (2017). Shotgun metagenomics, from sampling to analysis Nat Biotechnol 35:833-844.
  53. Franzosa EA, et al (2014). Relating the metatranscriptome and metagenome of the human gut Proc Natl Acad Sci USA 111:E2329-E2338.
  54. Zierer J, et al (2018). The fecal metabolome as a functional readout of the gut microbiome Nat Genet 50:790-795.
  55. Scheffler L, et al (2018). Widely used commercial ELISA does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the zonulin family Front Endocrinol 9:22.
  56. Mantis NJ, Rol N, Corthésy B (2011). Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut Mucosal Immunol 4:603-611.
  57. Ervin SM, et al (2019). Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens J Biol Chem 294:18586-18599.
  58. Roager HM, Licht TR (2018). Microbial tryptophan catabolites in health and disease Nat Commun 9:3294.
  59. Shalon D, et al (2023). Profiling the human intestinal environment under physiological conditions Nature 617:581-591.
  60. Zmora N, et al (2018). Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features Cell 174:1388-1405.
  61. Servetas SL, et al (2026). Evaluating the analytical performance of direct-to-consumer gut microbiome testing services Commun Biol 9:269.
  62. Hoffmann DE, et al (2024). The DTC microbiome testing industry needs more regulation Science 383:1176-1179.
  63. Vandeputte D, et al (2016). Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates Gut 65:57-62.
  64. Vandeputte D, et al (2021). Temporal variability in quantitative human gut microbiome profiles and implications for clinical research Nat Commun 12:6740.
  65. Duvallet C, et al (2017). Meta-analysis of gut microbiome studies identifies disease-specific and shared responses Nat Commun 8:1784.
  66. Asnicar F, et al (2026). Gut micro-organisms associated with health, nutrition and dietary interventions Nature 650:450-458.
  67. Patridge E, et al (2025). Altered gut microbial functional pathways in people with irritable bowel syndrome enable precision health insights BMC Gastroenterol 25:823.
  68. Diagnostic Solutions Laboratory (2025). GI-MAP interpretive guide, 2025 (manufacturer information)
  69. Gingras BA, Maggiore JA (2020). Performance of a new molecular assay for the detection of gastrointestinal pathogens Access Microbiol 2:acmi000160.
  70. Diagnostic Solutions Laboratory . Response to Doctor's Data Inc (DDI) funded study (manufacturer response)
  71. Bermingham KM, et al (2024). Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial Nat Med 30:1888-1897.
  72. Ben-Yacov O, et al (2021). Personalized postprandial glucose response-targeting diet versus Mediterranean diet for glycemic control in prediabetes Diabetes Care 44:1980-1991.
  73. Verweij JJ, Stensvold CR (2014). Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections Clin Microbiol Rev 27:371-418.
  74. Eckburg PB, et al (2005). Diversity of the human intestinal microbial flora Science 308:1635-1638.
  75. Nyssen OP, Espada M, Gisbert JP (2022). Empirical vs. susceptibility-guided treatment of Helicobacter pylori infection: a systematic review and meta-analysis Front Microbiol 13:913436.
  76. Roberts T, et al (2011). Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of Blastocystis sp. in clinical stool samples Am J Trop Med Hyg 84:308-312.
  77. Stark D, et al (2011). Evaluation of multiplex tandem real-time PCR for detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in clinical stool samples J Clin Microbiol 49:257-262.
  78. Klem F, et al (2017). Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis Gastroenterology 152:1042-1054.
  79. Seelbinder B, et al (2020). Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria Microbiome 8:133.
  80. Palleja A, et al (2018). Recovery of gut microbiota of healthy adults following antibiotic exposure Nat Microbiol 3:1255-1265.
  81. NICE . Faecal microbiota transplant for recurrent Clostridioides difficile infection (HTG638, formerly MTG71)
  82. van Nood E, et al (2013). Duodenal infusion of donor feces for recurrent Clostridium difficile N Engl J Med 368:407-415.
  83. Zhang F, et al (2012). Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol 107:1755.
  84. de Groot PF, Frissen MN, de Clercq NC, Nieuwdorp M (2017). Fecal microbiota transplantation in metabolic syndrome: history, present and future Gut Microbes 8:253-267.
  85. Tap J, et al (2017). Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome Gastroenterology 152:111-123.
  86. Kashyap P, et al (2024). Critical appraisal of the SIBO hypothesis and breath testing: a clinical practice update endorsed by ESNM and ANMS Neurogastroenterol Motil 36:e14817.
  87. Losurdo G, et al (2020). Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: a systematic review with meta-analysis J Neurogastroenterol Motil 26:16-28.
  88. Lim J, Rezaie A (2023). Pros and cons of breath testing for small intestinal bacterial overgrowth and intestinal methanogen overgrowth Gastroenterol Hepatol (N Y) 19:140-146.
  89. Lin EC, Massey BT (2016). Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth Clin Gastroenterol Hepatol 14:203-208.
  90. Yu D, Cheeseman F, Vanner S (2011). Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS Gut 60:334-340.
  91. Erdogan A, Rao SSC (2015). Small intestinal fungal overgrowth Curr Gastroenterol Rep 17:16.
  92. Gatta L, Scarpignato C (2017). Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth Aliment Pharmacol Ther 45:604-616.
  93. Zeber-Lubecka N, et al (2016). Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome Gut Microbes 7:397-413.
  94. Wang Shuhe (c. 280 CE). Mai Jing (The Pulse Classic) English translation: Yang Shou-zhong. Boulder: Blue Poppy Press; 1997.
  95. Li Shizhen (1564). Bin Hu Mai Xue (The Lakeside Master's Study of the Pulse) English translation: Flaws B. Boulder: Blue Poppy Press; 1998.
  96. Sharangadhara (c. 13th to 14th century CE). Sharangadhara Samhita (Purva Khanda, chapter on nadi pariksha) English translation: Murthy KRS. Varanasi: Chaukhambha Orientalia.
  97. Lad V (1996). Secrets of the Pulse: The Ancient Art of Ayurvedic Pulse Diagnosis Albuquerque: The Ayurvedic Press.
  98. Smith KA (2012). Louis Pasteur, the father of immunology? Front Immunol 3:68.
  99. Tan CY, Ramirez ZE, Surana NK (2021). A modern-world view of host-microbiota-pathogen interactions J Immunol 207:1710-1718.
  100. Casadevall A, Pirofski LA (2003). The damage-response framework of microbial pathogenesis Nat Rev Microbiol 1:17-24.
  101. Bensoussan A, et al (1998). Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial JAMA 280:1585-1589.
  102. Hong SW, et al (2018). Aloe vera is effective and safe in short-term treatment of irritable bowel syndrome: a systematic review and meta-analysis J Neurogastroenterol Motil 24:528-535.
  103. Vasant DH, et al (2021). British Society of Gastroenterology guidelines on the management of irritable bowel syndrome Gut 70:1214-1240.
  104. NICE . Irritable bowel syndrome in adults: diagnosis and management (CG61)
  105. Black CJ, et al (2020). Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis Gut 69:1441-1451.
  106. Flik CE, et al (2019). Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial Lancet Gastroenterol Hepatol 4:20-31.
  107. Jeitler M, et al (2021). Ayurvedic vs. conventional nutritional therapy including low-FODMAP diet for patients with irritable bowel syndrome: a randomized controlled trial Front Med (Lausanne) 8:622029.
  108. Zheng HZ, et al (2026). Acupuncture vs sham non-acupoint acupuncture for irritable bowel syndrome: a systematic review and meta-analysis Gastroenterology. Published online 7 July 2026.
  109. Shahamat M, et al (2016). Dry cupping in children with functional constipation: a randomized open label clinical trial Afr J Tradit Complement Altern Med 13:22-28.
  110. Delgado ME, Benet J, Herrero-Fresneda I (2026). Safety and efficacy of manual and automated abdominal colonic massage for chronic constipation: a systematic review and meta-analysis Clin Transl Gastroenterol 17:e01027.
  111. Yang JW, et al (2025). Efficacy of acupuncture in irritable bowel syndrome (ACTION): a multicenter randomized controlled trial Gastroenterology 169:958-969.
  112. McDonald D, et al (2018). American Gut: an open platform for citizen science microbiome research mSystems 3:e00031-18.
  113. Wastyk HC, et al (2021). Gut-microbiota-targeted diets modulate human immune status Cell 184:4137-4153.
  114. Clarke SF, et al (2014). Exercise and associated dietary extremes impact on gut microbial diversity Gut 63:1913-1920.
  115. Fasano A (2020). All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases F1000Res 9:F1000 Faculty Rev-69.
  116. Massier L, et al (2021). Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability Gut 70:1801-1802.
  117. Ponziani FR, et al (2017). Eubiotic properties of rifaximin: disruption of the traditional concepts in gut microbiota modulation World J Gastroenterol 23:4491-4499.
  118. Government of Malta, Screening Programmes (2026). Colorectal screening: scope of the programme (accessed 12 October 2026)